2.55 USD
▲+0.45+6.69%
盘后 2.23 -6.69%
2026-08-03
市值
$11.56M
市盈率
—
EPS
-46.23
股息率
—
52 周区间
1.21 – 21.58
成交量
845.19K
Beta
0.35
目标价
—
52W 低 1.2152W 高 21.58
价格走势
公司简介
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its rec...